Correction to Bifunctional Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Mechanism and Proof-of-Concept as a Novel Therapeutic Design Strategy — Christopher M. Bailey (2013) | RDL Network
Correction to Bifunctional Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Mechanism and Proof-of-Concept as a Novel Therapeutic Design Strategy
Shilpa N. Raja, Andrew C. K. Olson, Kari Thorkelsson, Andrew J. Luong, Lillian Hsueh, Guoqing Chang, Bernd Gludovatz, Liwei Lin, Ting Xu, Robert O. Ritchie, Paul Alivisatos
Discussion(0)
No comments yet. Be the first to comment.